GB0812277D0 - Antibody and uses thereof - Google Patents

Antibody and uses thereof

Info

Publication number
GB0812277D0
GB0812277D0 GBGB0812277.2A GB0812277A GB0812277D0 GB 0812277 D0 GB0812277 D0 GB 0812277D0 GB 0812277 A GB0812277 A GB 0812277A GB 0812277 D0 GB0812277 D0 GB 0812277D0
Authority
GB
United Kingdom
Prior art keywords
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0812277.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fusion Antibodies Ltd
Original Assignee
Fusion Antibodies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fusion Antibodies Ltd filed Critical Fusion Antibodies Ltd
Priority to GBGB0812277.2A priority Critical patent/GB0812277D0/en
Publication of GB0812277D0 publication Critical patent/GB0812277D0/en
Priority to PCT/EP2009/058535 priority patent/WO2010000875A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB0812277.2A 2008-07-04 2008-07-04 Antibody and uses thereof Ceased GB0812277D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0812277.2A GB0812277D0 (en) 2008-07-04 2008-07-04 Antibody and uses thereof
PCT/EP2009/058535 WO2010000875A1 (en) 2008-07-04 2009-07-06 Erythropoietin receptor antibody and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0812277.2A GB0812277D0 (en) 2008-07-04 2008-07-04 Antibody and uses thereof

Publications (1)

Publication Number Publication Date
GB0812277D0 true GB0812277D0 (en) 2008-08-13

Family

ID=39717989

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0812277.2A Ceased GB0812277D0 (en) 2008-07-04 2008-07-04 Antibody and uses thereof

Country Status (2)

Country Link
GB (1) GB0812277D0 (en)
WO (1) WO2010000875A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3154580B1 (en) * 2014-06-12 2020-03-25 Andremacon S.r.l. Use of negative functional modulators of erythropoietin for therapy
CN105542006A (en) * 2015-12-11 2016-05-04 北京大学第一医院 Preparation method and use of anti-EPOR fusion protein antibody

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885574A (en) * 1994-07-26 1999-03-23 Amgen Inc. Antibodies which activate an erythropoietin receptor
BR9910568A (en) * 1998-04-30 2001-09-11 Tanox Inc Agonist g-csf receptor antibodies and selection process for them
JP2002544123A (en) * 1999-04-14 2002-12-24 スミスクライン・ビーチャム・コーポレイション Erythropoietin receptor antibody
PL2511301T3 (en) * 2006-08-04 2018-05-30 Medimmune Limited Human antibodies to erbb 2
BRPI0716997B8 (en) * 2006-09-10 2021-05-25 Glycotope Gmbh protein or composition of protein molecules, methods for producing and using it
KR100890463B1 (en) * 2006-09-19 2009-03-26 성균관대학교산학협력단 Antiviral agent against animal viruses

Also Published As

Publication number Publication date
WO2010000875A1 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
IL209309A0 (en) Anti-fn14 antibodies and uses thereof
IL216731A (en) P95-her2 antibodies and uses thereof
PT2099826E (en) Anti-beta-amyloid antibody and uses thereof
IL200012A0 (en) Anti-robo4 antibodies and uses therefor
HK1142341A1 (en) Anti-hepcidin antibodies and uses thereof
EP2236604A4 (en) Anti-nr10 antibody and use thereof
IL210804A (en) Benzylidenehydrazides and uses thereof
EP2354161A4 (en) Anti-nr10 antibody, and use thereof
HK1156326A1 (en) Anti-hepcidin-25 selective antibodies and uses thereof
IL207129A0 (en) Ron antibodies and uses thereof
HK1195776A1 (en) Anti-51 antibodies and uses thereof -51
IL236237A (en) Tmem154 antibodies and fragments and uses thereof
IL220536A0 (en) Anti - bv8 antibodies and uses thereof
HK1203206A1 (en) Antibody and use thereof
ZA201103456B (en) Leukolectins and uses thereof
EP2291377A4 (en) Imidazopyrimidinones and uses thereof
HK1210026A1 (en) Thiol-functionalising reagents and their uses
SI2354161T1 (en) Anti-nr10 antibody, and use thereof
EP2247601A4 (en) Thiazopyrimidinones and uses thereof
EP2388320A4 (en) Anti-hs6st2 antibodies and use thereof
GB0903151D0 (en) Antibody uses and methods
IL214527A0 (en) Anti-mst1r antibodies and uses thereof
HK1158977A1 (en) Anti-ferroportin monoclonal antibodies and uses thereof
GB0812277D0 (en) Antibody and uses thereof
GB0906115D0 (en) Antibody and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)